Loading...

Abbvie Inc (NYSE:ABBV)

152.34 USD +2.89 USD ( +1.93% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

Net Margin

Net Margin measures how much net income is generated as a percentage of revenues received.

Net margin helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Current Net Margin
ABBV
22%
Average Net Margin
ABBV
16.4%
Industry Net Margin
Biotechnology
5.2%

Net Margin History

Statistics
Net Margin

1 Year 3 Years 5 Years
Average 15.8% 16.4% 18.5%
Median 13.7% 16.4% 19.2%
Min 10.3% 9.9% 9.9%
Max 22% 24.8% 24.8%

History Chart
Net Margin

Net Margin Across Competitors

Net Margin Comparison
Abbvie Inc Competitors

Country Company Market Cap Net
Margin
US
Abbvie Inc
NYSE:ABBV
269B USD
22%
US
Amgen Inc
NASDAQ:AMGN
131B USD
22%
AU
CSL Ltd
ASX:CSL
128B AUD
22%
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD
16%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD
31%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.1B USD
48%
Country US
Market Cap 269B USD
Net Margin
22%
Country US
Market Cap 131B USD
Net Margin
22%
Country AU
Market Cap 128B AUD
Net Margin
22%
Country US
Market Cap 79.2B USD
Net Margin
16%
Country US
Market Cap 74.8B USD
Net Margin
31%
Country US
Market Cap 67.1B USD
Net Margin
48%

Profitability Report

View the profitability report to see the full profitability analysis for Abbvie Inc.

See Also

Similar Stocks